Tumour Necrosis Factor-alpha Converting Enzyme in Human Gestational Tissues from Pregnancies Complicated by Chorioamnionitis

Placenta

Volumn 27, Issue 9-10, 2006, Pages 996-1006

  Hung, T H ^a   Chen, S F ^b   Hsu, J J ^a   Hsieh, C C ^a   Hsueh, S ^a   Hsieh, T T ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

Chorioamnionitis; Placenta; Tumour necrosis factor alpha; Tumour necrosis factor alpha converting enzyme

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AMNION; ARTICLE; CELL INFILTRATION; CEREBRAL PALSY; CHORIOAMNIONITIS; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DECIDUA; EXPLANT; FEMALE; FETUS; FETUS MEMBRANE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MONOCYTE; PATHOGENESIS; PLACENTA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STROMA CELL; SYNCYTIOTROPHOBLAST; WESTERN BLOTTING;

ADAM PROTEINS; CHORIOAMNIONITIS; EXTRAEMBRYONIC MEMBRANES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIPOPOLYSACCHARIDES; MACROPHAGES; PLACENTA; PREGNANCY; RNA, MESSENGER;

EID: 33747002234     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2005.11.002     Document Type: Article

References (40)

1. Dammann O., and Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 42 (1997) 1-8
2. Mueller-Heubach E., Rubinstein D.N., and Schwarz S.S. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 75 (1990) 622-626
3. Goldenberg R.L., Hauth J.C., and Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 342 (2000) 1500-1507
4. Markenson G.R., Martin R.K., Tillotson-Criss M., Foley K.S., Stewart Jr. R.S., and Yancey M. The use of the polymerase chain reaction to detect bacteria in amniotic fluid in pregnancies complicated by preterm labor. Am J Obstet Gynecol 177 (1997) 1471-1477
5. Watts D.H., Krohn M.A., Hillier S.L., and Eschenbach D.A. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 79 (1992) 351-357
6. Yoon B.H., Romero R., Moon J.B., Shim S.S., Kim M., Kim G., et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 185 (2001) 1130-1136
7. Gaudet L.M., and Smith G.N. Cerebral palsy and chorioamnionitis: the inflammatory cytokine link. Obstet Gynecol Surv 56 (2001) 433-436
8. Ramsey P.S., Lieman J.M., Brumfield C.G., and Carlo W. Chorioamnionitis increases neonatal morbidity in pregnancies complicated by preterm premature rupture of membranes. Am J Obstet Gynecol 192 (2005) 1162-1166
9. Romero R., Salafia C.M., Athanassiadis A.P., Hanaoka S., Mazor M., Sepulveda W., et al. The relationship between acute inflammatory lesions of the preterm placenta and amniotic fluid microbiology. Am J Obstet Gynecol 166 (1992) 1382-1388
10. Saji F., Samejima Y., Kamiura S., Sawai K., Shimoya K., and Kimura T. Cytokine production in chorioamnionitis. J Reprod Immunol 47 (2000) 185-196
11. Bowen J.M., Chamley L., Keelan J.A., and Mitchell M.D. Cytokines of the placenta and extra-placental membranes: roles and regulation during human pregnancy and parturition. Placenta 23 (2002) 257-273
12. Romero R., Mazor M., Sepulveda W., Avila C., Copeland D., and Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 166 (1992) 1576-1587
13. Romero R., Manogue K.R., Mitchell M.D., Wu Y.K., Oyarzun E., Hobbins J.C., et al. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am J Obstet Gynecol 161 (1989) 336-341
14. Lappas M., Permezel M., Georgiou H.M., and Rice G.E. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67 (2002) 668-673
15. Zaga V., Estrada-Gutierrez G., Beltran-Montoya J., Maida-Claros R., Lopez-Vancell R., and Vadillo-Ortega F. Secretions of interleukin-1beta and tumor necrosis factor alpha by whole fetal membranes depend on initial interactions of amnion or choriodecidua with lipopolysaccharides or group B streptococci. Biol Reprod 71 (2004) 1296-1302
16. Fortunato S.J., Menon R.P., Swan K.F., and Menon R. Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations. Am J Obstet Gynecol 174 (1996) 1855-1861
17. Hanada T., and Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 13 (2002) 413-421
18. McGeehan G.M., Becherer J.D., Bast Jr. R.C., Boyer C.M., Champion B., Connolly K.M., et al. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 370 (1994) 558-561
19. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
20. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 (1997) 733-736
21. Black R.A. Tumor necrosis factor-[alpha] converting enzyme. Int J Biochem Cell Biol 34 (2002) 1-5
22. Mezyk R., Bzowska M., and Bereta J. Structure and functions of tumor necrosis factor-alpha converting enzyme. Acta Biochimica Polonica 50 (2003) 625-645
23. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 274 (1998) R577-R595
24. Hunt J.S., Chen H.L., and Miller L. Tumor necrosis factors: pivotal components of pregnancy?. Biol Reprod 54 (1996) 554-562
25. Romero R., Kadar N., Hobbins J.C., and Duff G.W. Infection and labor: the detection of endotoxin in amniotic fluid. Am J Obstet Gynecol 157 (1987) 815-819
26. Hung T.H., Skepper J.N., Charnock-Jones D.S., and Burton G.J. Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90 (2002) 1274-1281
27. Hung T.H., Charnock-Jones D.S., Skepper J.N., and Burton G.J. Secretion of tumor necrosis factor-{alpha} from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 164 (2004) 1049-1061
28. Satoh M., Nakamura M., Saitoh H., Satoh H., Maesawa C., Segawa I., et al. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. Circulation 99 (1999) 3260-3265
29. Gomez M.I., Sokol S.H., Muir A.B., Soong G., Bastien J., and Prince A.S. Bacterial induction of TNF-{alpha} converting enzyme expression and IL-6 receptor {alpha} shedding regulates airway inflammatory signaling. J Immunol 175 (2005) 1930-1936
30. Patel I.R., Attur M.G., Patel R.N., Stuchin S.A., Abagyan R.A., Abramson S.B., et al. TNF-{alpha} convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-{alpha}. J Immunol 160 (1998) 4570-4579
31. Vince G., Shorter S., Starkey P., Humphreys J., Clover L., Wilkins T., et al. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol 88 (1992) 174-180
32. Sweet M.J., and Hume D.A. Endotoxin signal transduction in macrophages. J Leukoc Biol 60 (1996) 8-26
33. Lee J.C., and Young P.R. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J Leukoc Biol 59 (1996) 152-157
34. Bzowska M., Jura N., Lassak A., Black R.A., and Bereta J. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. Eur J Biochem 271 (2004) 2808-2820
35. Baumann P., Romero R., Berry S., Gomez R., McFarlin B., Araneda H., et al. Evidence of participation of the soluble tumor necrosis factor receptor I in the host response to intrauterine infection in preterm labor. Am J Reprod Immunol 30 (1993) 184-193
36. Dollner H., Vatten L., Halgunset J., Rahimipoor S., and Austgulen R. Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and cytokine inhibitors. Br J Obstet Gynaecol 109 (2002) 534-539
37. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7 (1996) 231-240
38. Cornette L. Fetal and neonatal inflammatory response and adverse outcome. Semin Fetal Neonatal Med 9 (2004) 459-470
39. Doggrell S.A. TACE inhibition: a new approach to treating inflammation. Expert Opin Invest Drugs 11 (2002) 1003-1006
40. Zhang Y., Hegen M., Xu J., Keith Jr. J.C., Jin G., Du X., et al. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme. Int Immunopharmacol 4 (2004) 1845-1857